Publicaciones en las que colabora con JUAN VICENTE ESPLUGUES MOTA (41)

2024

  1. Benefits of rilpivirine for liver stiffness in HIV/HCV-coinfected patients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 2, pp. 74-79

  2. Bictegravir alters glucose tolerance in vivo and causes hepatic mitochondrial dysfunction

    Antiviral Research, Vol. 231

  3. Integrated transcriptomic landscape of the effect of anti-steatotic treatments in high-fat diet mouse models of non-alcoholic fatty liver disease

    Journal of Pathology, Vol. 262, Núm. 3, pp. 377-389

  4. Interference with mitochondrial function as part of the antifibrogenic effect of Rilpivirine: A step towards novel targets in hepatic stellate cell activation

    Biomedicine and Pharmacotherapy, Vol. 178

  5. Rilpivirine Activates STAT1 in Non-Parenchymal Cells to Regulate Liver Injury in People Living with HIV and MASLD

    Biomedicines, Vol. 12, Núm. 7

2023

  1. Anti-inflammatory and immunomodulating effects of rilpivirine: Relevance for the therapeutics of chronic liver disease

    Biomedicine and Pharmacotherapy, Vol. 167

2022

  1. Down-Regulation of the Longevity-Associated Protein SIRT1 in Peripheral Blood Mononuclear Cells of Treated HIV Patients

    Cells, Vol. 11, Núm. 3

  2. Implication of autophagy in the antifibrogenic effect of Rilpivirine: when more is less

    Cell Death and Disease, Vol. 13, Núm. 4

  3. Macrophages Modulate Hepatic Injury Involving NLRP3 Inflammasome: The Example of Efavirenz

    Biomedicines, Vol. 10, Núm. 1

2021

  1. Apoptosis of Hepatocytes: Relevance for HIV-Infected Patients under Treatment

    Cells, Vol. 10, Núm. 2

  2. NNRTI and Liver Damage: Evidence of Their Association and the Mechanisms Involved

    Cells, Vol. 10, Núm. 7

  3. Understanding the implication of autophagy in the activation of hepatic stellate cells in liver fibrosis: are we there yet?

    Journal of Pathology, Vol. 254, Núm. 3, pp. 216-228

2020

  1. Differential Effects of Biologics on Psoriasis-Related Vascular Inflammation and Risk of Thrombosis

    Journal of Investigative Dermatology, Vol. 140, Núm. 11, pp. 2294-2298.e6

  2. Rilpivirine attenuates liver fibrosis through selective STAT1-mediated apoptosis in hepatic stellate cells

    Gut, Vol. 69, Núm. 5, pp. 920-932

  3. p53 and p53-related mediators PAI-1 and IGFBP-3 are downregulated in peripheral blood mononuclear cells of HIV-patients exposed to non-nucleoside reverse transcriptase inhibitors

    Antiviral Research, Vol. 178

2019

  1. Mitophagy in human astrocytes treated with the antiretroviral drug Efavirenz: Lack of evidence or evidence of the lack

    Antiviral Research, Vol. 168, pp. 36-50

2018

  1. Abacavir induces arterial thrombosis in a murine model

    Journal of Infectious Diseases

  2. Role of p62/SQSTM1 beyond autophagy: a lesson learned from drug-induced toxicity in vitro

    British Journal of Pharmacology, Vol. 175, Núm. 3, pp. 440-455

2017

  1. Efavirenz: What is known about the cellular mechanisms responsible for its adverse effects

    European Journal of Pharmacology, Vol. 812, pp. 163-173

  2. Ensuring the consistency of biosimilars

    Current Pharmaceutical Design, Vol. 23, Núm. 44, pp. 6733-6738